Genentech, Novartis Sue Amneal Over Bid To Sell Xolair Copy
Genentech Inc. and Novartis Pharmaceuticals Corp. have filed a patent infringement suit in Delaware federal court, claiming Kashiv BioSciences' bid to sell a biosimilar copy of their prescription allergy drug Xolair...To view the full article, register now.
Already a subscriber? Click here to view full article